bropair spiromax
teva b.v. - salmeterol xinafoate, flútikasón nef - astma - lyf til veikindi öndunarvegi sjúkdómum, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
neotigason hart hylki 25 mg
teva b.v.* - acitretinum inn - hart hylki - 25 mg
neotigason hart hylki 10 mg
teva b.v.* - acitretinum inn - hart hylki - 10 mg
hjartamagnýl magasýruþolin tafla 75 mg
teva b.v.* - acidum acetylsalicylicum - magasýruþolin tafla - 75 mg
impugan tafla 20 mg
teva b.v.* - furosemidum inn - tafla - 20 mg
histasín filmuhúðuð tafla 10 mg
teva b.v.* - cetirizinum díhýdróklóríð - filmuhúðuð tafla - 10 mg
copaxone stungulyf, lausn í áfylltri sprautu 40 mg/ml
teva gmbh - glatiramer acetat - stungulyf, lausn í áfylltri sprautu - 40 mg/ml
lóritín tafla 10 mg
teva b.v.* - loratadinum inn - tafla - 10 mg
amló tafla 5 mg
teva b.v.* - amlodipinum besýlat - tafla - 5 mg